Grants per year
Fingerprint
Dive into the research topics where Santosh Kesari is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 8 Finished
-
PHASE 2 STUDY OF VASCULAR-TARGETED PRODRUG (G-202) FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA
Kesari, S. (PI) & Zanetti, M. (CoPI)
U.S. Food and Drug Administration
04/20/15 → 03/31/19
Project: Research
-
PHASE 2 STUDY OF VASCULAR-TARGETED PRODRUG (G-202) FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA
Kesari, S. (PI) & Zanetti, M. (CoPI)
U.S. Food and Drug Administration
04/20/15 → 03/31/19
Project: Research
-
PHASE 2 STUDY OF VASCULAR-TARGETED PRODRUG (G-202) FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA
Kesari, S. (PI) & Zanetti, M. (CoPI)
U.S. Food and Drug Administration
04/20/15 → 03/31/19
Project: Research
-
Validation of a Novel Treatment for Glioblastoma
Stein, G. (PI) & Kesari, S. (CoPI)
09/24/14 → 08/31/15
Project: Research
-
A radiotherapeutic for breast cancer brain metastases
Kesari, S. (CoPI) & Makale, M. T. (CoPI)
08/1/14 → 07/31/16
Project: Research
-
A Health Care Clinical Data Platform for Rapid Deployment of Artificial Intelligence and Machine Learning Algorithms for Cancer Care and Oncology Clinical Trials
Sengupta, S., Rao, R., Kaufman, Z., Stuhlmiller, T. J., Wong, K. K., Kesari, S., Shapiro, M. A. & Kramer, G. A., Jul 1 2024, In: North Carolina Medical Journal. 85, 4, p. 270-273 4 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
A Microfluidic, Multi-Antibody Cell Capture Method to Evaluate Tumor Cells in Cerebrospinal Fluid in Patients With Suspected Leptomeningeal Metastases.
Sweed, N. T., Hsiao, H.-C., Blouw, B., Pircher, T. J., Fisher, D., Naluz, K. R., Mayer, J. A., Dugan, M. C., Sharma, A., Carrillo, J. & Kesari, S., May 27 2024, In: Articles, Abstracts, and Reports.Research output: Contribution to journal › Article
-
A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer
Juarez, T. M., Gill, J. M., Heng, A., Carrillo, J. A., Wagle, N., Nomura, N., Nguyen, M., Truong, J., Dobrawa, L., Sivakumar, W., Barkhoudarian, G., Kelly, D. F. & Kesari, S., Jan 1 2024, In: Neuro-Oncology Advances. 6, 1, vdae049.Research output: Contribution to journal › Article › peer-review
Open Access -
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
Latzer, P., Zelba, H., Battke, F., Reinhardt, A., Shao, B., Bartsch, O., Rabsteyn, A., Harter, J., Schulze, M., Okech, T., Golf, A., Kyzirakos-Feger, C., Kayser, S., Pieper, N., Feldhahn, M., Wünsche, J., Seitz, C., Hadaschik, D., Garbe, C. & Hauser, T. K. & 30 others, , Dec 2024, In: Nature Communications. 15, 1, 6870.Research output: Contribution to journal › Article › peer-review
Open Access -
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors
Conley, A. P., Roland, C. L., Bessudo, A., Gastman, B. R., Villaflor, V. M., Larson, C., Reid, T. R., Caroen, S., Oronsky, B., Stirn, M., Williams, J., Burbano, E., Coyle, A., Barve, M. A., Wagle, N., Abrouk, N. & Kesari, S., Apr 2024, In: Cancer Gene Therapy. 31, 4, p. 517-526 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations